Sponsor:
M.D. Anderson Cancer Center
Code:
NCT05007873
Conditions
Chronic Phase Chronic Myelogenous Leukemia
Philadelphia Chromosome Positive
BCR-ABL1 Positive Chronic Myelogenous Leukemia
BCR-ABL1 Positive
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
Dasatinib
Decitabine and Cedazuridine
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations